tm logo
RESVIVAX
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 07 Dec 2023

Last Applicant/ Owned by

21 Firstfield Road

Gaithersburg

MD

20878

Serial Number

88888237 filed on 26th Apr 2020

Registration Number

N/A

Correspondent Address

Caroline L. Marsili

Carlson, Caspers, Vandenburgh & Lindquis

225 S. Sixth Street, Suite 4200

c/o Docketing Department

Minneapolis,MN 55402

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RESVIVAX

Pharmaceutical, biologic, and vaccine research and development for human use; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants, all for human use; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, all for human use Vaccines for human use; vaccine adjuvants Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical, biologic, and vaccine research and development for human use; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants, all for human use; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, all for human use

Class [005]
Pharmaceutical Products


Vaccines for human use; vaccine adjuvants for human use

Mark Details


Serial Number

No 88888237

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Mar 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04th Mar 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04th Mar 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
08th Dec 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Dec 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
07th Dec 2023SOU EXTENSION 5 GRANTED
27th Nov 2023SOU TEAS EXTENSION RECEIVED
27th Nov 2023SOU EXTENSION 5 FILED
15th Apr 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Apr 2023SOU TEAS EXTENSION RECEIVED